10/22/2026
VA faces challenges in psychedelic treatment rollout
Federal officials discuss the complexities of psychedelic access for veterans.
Topic archive
arpa h
4 stories
10/6/2026
FDA seeks public input on ibogaine trial design
Request focuses on safety, dosing, and oversight for early-phase trials.
9/22/2026
NIH funds ibogaine study for opioid addiction with heart safety focus
Brigham and Women's Hospital receives $2.3 million to assess ibogaine's safety for opioid use disorder.
9/1/2026
ARPA-H backs ibogaine research amid rising pharma ad spend
Pharmaceutical companies increase ad budgets for psychedelic terms as ARPA-H funds ibogaine studies.